A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

References

• Alper, K. R., H. S. Lotsof, G. M. Frenken, D. J. Luciano, and J. Bastiaans. 1999. Treatment of acute opioid withdrawal with ibogaine. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 8:234–42. doi:10.1080/105504999305848.
   PubMed Web of Science ®Google Scholar
• Andersen, J. M., C. F. Olaussen, Å. Ripel, and J. Mørland. 2011. Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue. Pharmacology, Biochemistry, and Behavior 98:412–16. doi:10.1016/j.pbb.2011.02.017.
   PubMed Web of Science ®Google Scholar
• Baarendse, P., J. Limpens, and L. Vanderschuren. 2014. Disrupted social development enhances the motivation for cocaine in rats. Psychopharmacology 231:1695–704. doi:10.1007/s00213-013-3362-8.
   PubMed Web of Science ®Google Scholar
• Bastiaans, E. 2004. Life after Ibogaine: An exploratory study of the long-term effects of ibogaine treatment on drug addicts. www.ibogaine.desk.nl/ibogaine_udi_bastiaans.pdf.
   Google Scholar
• Blume, A. W. 2001. Negative reinforcement and substance abuse: Using a behavioral conceptualization to enhance treatment. The Behavior Analyst Today 2:86–90.
   Google Scholar
• Bogenschutz, M. P., and M. W. Johnson. 2016. Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology & Biological Psychiatry 64:250–58. doi:10.1016/j.pnpbp.2015.03.002.
   PubMed Web of Science ®Google Scholar
• Brown, T. K., and K. Alper. 2017. Treatment of opioid use disorder with ibogaine: Detoxification and drug use outcomes. The American Journal of Drug and Alcohol Abuse 1–13. doi:10.1080/00952990.2017.1320802.
   Web of Science ®Google Scholar
• Casterlé, B., C. Gastmans, E. Bryon, and Y. Denier. 2012. QUAGOL: A guide for qualitative data analysis. International Journal of Nursing Studies 49:360–71. doi:10.1016/j.ijnurstu.2011.09.012.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2016. Drug overdose deaths in the United States hit record numbers in 2014. Accessed June 21, 2016. https://www.cdc.gov/drugoverdose/epidemic/.
   Google Scholar
• Davis, A. K., J. Barsuglia, M. Windam-Herman, M. Lynch, and M. Polanco. 2017. Effectiveness of Ibogaine-assisted treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. Journal of Psychedelic Studies 1:65–73. doi:10.1556/2054.01.2017.009.
   PubMedGoogle Scholar
• Davis, J. H. 2017. Trump declares the opioid crisis a “Public Health Emergency.” NY Times. https://www.nytimes.com/2017/10/26/us/politics/trump-opioid-crisis.html.
   Google Scholar
• Degenhardt, L., F. Charlson, B. Mathers, W. D. Hall, A. D. Flaxman, N. Johns, and T. Vos. 2014. The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study. Addiction 109:1320–33. doi:10.1111/add.12551.
   PubMed Web of Science ®Google Scholar
• Doblin, R. 1991. Pahnke’s Good Friday experiment: A long-term follow-up and methodological critique. Journal of Transpersonal Psychology 23:1–28.
   Google Scholar
• Griffiths, R. R., M. W. Johnson, W. A. Richards, B. D. Richards, U. McCann, and R. Jesse. 2011. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218:649–65. doi:10.1007/s00213-011-2358-5.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, M. W. Johnson, U. D. McCann, R. Jesse, R. R. Griffiths, … U. D. McCann. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22:621–32. doi:10.1177/0269881108094300.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187:268–83. doi:10.1007/s00213-006-0457-5.
   PubMed Web of Science ®Google Scholar
• Johnson, J., and J. Wagner. 2017. Trump declares the opioid crisis a public health emergency. https://www.washingtonpost.com/news/post-politics/wp/2017/10/26/trump-plans-to-declare-the-opioid-crisis-a-public-health-emergency/?utm_term=.0391096cc23d.
   Google Scholar
• Lesscher, H. M., M. Spoelder, M. D. Rotte, M. J. Janssen, P. Hesseling, J. G. Lozeman-Van’t Klooster, … L. J. Vanderschuren. 2015. Early social isolation augments alcohol consumption in rats. Behavioural Pharmacology 26:673–s80. doi:10.1097/FBP.0000000000000165.
   PubMed Web of Science ®Google Scholar
• Ling, W., and P. Compton. 2005. Recent advances in the treatment of opiate addiction. Clinical Neuroscience Research 5:161–67. doi:10.1016/j.cnr.2005.08.012.
   Web of Science ®Google Scholar
• Mash, D. C., C. A. Kovera, J. Pablo, R. Tyndale, F. R. Ervin, J. D. Kamlet, and W. L. Hearn. 2001. Ibogaine in the treatment of heroin withdrawal. The Alkaloids 56:155–71.
   PubMedGoogle Scholar
• Miles, M., and A. Huberman. 1994. Qualitative data analysis: An expanded sourcebook. 2nd ed. Thousand Oaks, CA: Sage Publications.
   Google Scholar
• National Council on Alcoholism and Drug Dependence NCADD. 2016. Shortage of addiction treatment personnel intensifies as opioid crisis worsens. https://www.ncadd.org/blogs/in-the-news/shortage-of-addiction-treatment-personnel-intensifies-as-opioid-crisis-worsens.
   Google Scholar
• Nielsen, S., B. Larance, L. Degenhardt, L. Gowing, C. Kehler, and N. Lintzeris. 2016. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews 2016. doi:10.1002/14651858.CD011117.pub2.
   Web of Science ®Google Scholar
• Noller, G. E., C. M. Frampton, and B. Yazar-Klosinski. 2017. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse 1–10. doi:10.1080/00952990.2017.1310218.
   Web of Science ®Google Scholar
• Pahnke, W. N. 1969. Psychedelic drugs and mystical experience. International Journal of Psychiatry in Clinical Practice 5:149–62.
   Google Scholar
• Rezvani, A. H., M. C. Cauley, S. Slade, C. Wells, S. Glick, J. E. Rose, and E. D. Levin. 2016. Acute oral 18-methoxycoronaridine 18-MC decreases both alcohol intake and IV nicotine self-administration in rats. Pharmacology, Biochemistry And Behavior 150–151:153–57. doi:10.1016/j.pbb.2016.10.010.
   PubMed Web of Science ®Google Scholar
• Saloner, B., and S. Karthikeyan. 2015. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004–2013. Journal of the American Medical Association. http://jama.jamanetwork.com/article.aspx?articleid=2456156\npapers3://publication/doi/10.1001/jama.2015.10345.
   Web of Science ®Google Scholar
• Samoylenko, V., M. M. Rahman, B. L. Tekwani, L. M. Tripathi, Y.-H. Wang, S. I. Khan, I. A. Khan, L. S. Miller, V. C. Joshi, and I. Muhammad. 2010. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease. Journal of Ethnopharmacology 127:357–67. doi:10.1016/j.jep.2009.10.030.
   PubMed Web of Science ®Google Scholar
• Schenberg, E. E., M. A. De Castro Comis, J. F. M. Alexandre, B. D. R. Chaves, L. F. Tófoli, and D. X. Da Silveria. 2017. A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment. Journal of Psychedelic Studies :1–10. doi:10.1556/2054.01.2017.007.
   Google Scholar
• Schenberg, E. E., M. A. De Castro Comis, J. F. M. Alexandre, L. F. Tófoli, B. D. R. Chaves, and D. X. Da Silveria. 2016. Treating drug dependence with the aid of ibogaine: A qualitative study. Journal of Psychedelic Studies 1:10–19. doi:10.1556/2054.01.2016.002.
   Google Scholar
• Schenberg, E. E., M. A. De Castro Comis, B. R. Chaves, and D. X. Da Silveira. 2014. Treating drug dependence with the aid of ibogaine: A retrospective study. Journal of Psychopharmacology 28:993–1000. doi:10.1177/0269881114552713.
   PubMed Web of Science ®Google Scholar
• Sehgal, N., L. Manchikanti, and H. S. Smith. 2012. Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician 15:67–92.
   Web of Science ®Google Scholar
• Stotts, A. L., C. L. Dodrill, and T. R. Kosten. 2009. Opioid dependence treatment: Options in pharmacotherapy. Expert Opinion on Pharmacotherapy 10:1727–40. doi:10.1517/14656560903037168.
   PubMed Web of Science ®Google Scholar
• Strauss, A., and C. Juliet. 1994. Grounded theory methodology: An overview. In Handbook of qualitative research, ed. N. Denzin, and Y. Lincoln, 273–84. 1st ed. Thousand Oaks, CA: Sage Publications, Inc.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. 2015. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf.
   Google Scholar
• Tennant, F. 2013. Improvement in physiologic but not hormonal functions after 10 years of opioid treatment. 29th Annual Meeting of the American Academy of Pain Medicine AAPM, Fort Lauderdale, FL.
   Google Scholar
• Upadhyay, J., N. Maleki, J. Potter, I. Elman, D. Rudrauf, J. Knudsen, … D. Borsook. 2010. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 133:2098–114. doi:10.1093/brain/awq138.
   PubMed Web of Science ®Google Scholar
• Veilleux, J. C., P. J. Colvin, J. Anderson, C. York, and A. J. Heinz. 2010. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review 30:55–166. doi:10.1016/j.cpr.2009.10.006.
   Web of Science ®Google Scholar
• Weiss, R. D., J. S. Potter, D. A. Fiellin, M. Byrne, H. S. Connery, W. Dickinson, J. Gardin, M. L. Griffin, M. N. Gourevitch, D. L. Haller, et al. 2011. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 68:1238–46. doi:10.1001/archgenpsychiatry.2011.121.
   PubMed Web of Science ®Google Scholar